menu search

Alnylam pharmaceuticals: a good buy ahead of phase 3 data for vutrisiran

We rate Alnylam Pharmaceuticals, Inc.'s common stock a Buy on the dip after the complete response letter, CRL for Patisiran. The investment thesis is ...

October 13, 2023, 6:11 pm

Processa pharmaceuticals to present at the thinkequity conference

HANOVER, MD, Oct. 13, 2023 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage ...

October 13, 2023, 5:08 pm

Why novo nordisk stock raced higher today

The Danish pharmaceutical developer updated its 2023 guidance. It raised its projected growth rates for...

October 13, 2023, 4:56 pm

Syndax: biotech to watch with regulatory filings before end of 2023

Syndax Pharmaceuticals, Inc. reported positive results from its phase 1/2 trial using revumenib to treat relapsed/refractory leukemia patients. The tr...

October 13, 2023, 2:52 pm

: sanofi reaps rewards of immunology investment with eczema results

pharmaceutical giant set to take on Amgen with atopic dermatitis treatment. Read Full Story The post : ...

October 13, 2023, 2:00 pm

Processa pharmaceuticals to present at the thinkequity conference

HANOVER, MD, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage <...

October 13, 2023, 1:08 pm

: amylyx pharmaceuticals shares fall after als treatment is rejected by european regulator

Amylyx Pharmaceuticals Inc. AMLX shares fell 7.5% premarket on Friday after the company said the European Medicines Agency had confirmed its negative ...

October 13, 2023, 12:31 pm

Amylyx pharmaceuticals's als dug rejected again by eu regulators

Amylyx Pharmaceuticals shares fell Friday after its ALS (amyotrophic lateral sclerosis) drug was denied marketing authorization by European Union regu...

October 13, 2023, 11:38 am

Harmony biosciences stock drops on disappointing study results

Harmony Biosciences Holdings Inc shares sank 38% to $18.66 in late-morning trading on Friday after the pharmac...

October 13, 2023, 11:29 am

Eledon pharmaceuticals to present data from ongoing phase 1b trial of tegoprubart in patients undergoing kidney transplantation at the american society of nephrology kidney week 2023 annual meeting

IRVINE, Calif., Oct. 13, 2023 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that the Company will pr...

October 13, 2023, 11:00 am

Tiziana life sciences reveals positive pet scan results with foralumab to treat ms patients

Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that a reduction in activated microglia, as seen in six-month Positron Emission Tomography (PET) s...

October 13, 2023, 8:34 am

Amylyx pharmaceuticals shares fall after als treatment is rejected by european regulator

Amylyx Pharmaceuticals Inc. AMLX, -4.60% shares fell 7.5% premarket on Friday after the company said the European Medicines Agency had confirmed its n...

October 13, 2023, 8:31 am

Eu regulator declines to recommend amylyx' als drug

Amylyx Pharmaceuticals said on Friday the European Union medicines regulator for the second time declined to recommend a marketing authorisation for t...

October 13, 2023, 8:28 am

Ardelyx to present data updates for xphozah (tenapanor) for hyperphosphatemia at kidney week 2023 november 1-5 in philadelphia, pa

WALTHAM, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical com...

October 13, 2023, 8:00 am

Mint & needle launches nonprofit initiative providing free medical aesthetic services for abuse survivors

MIDDLETOWN, Del., Oct. 12, 2023 (GLOBE NEWSWIRE) — Empowerment Beyond Scars, a new nonprofit organization dedicated to healing both visible and hidd...

October 12, 2023, 4:56 pm

The surprising $5 billion opportunity that drove vertex pharmaceuticals stock to a record high

Almost three-quarters of prescribed pain meds are opioids, and Vertex could change that. VRTX stock broke out to a record high Thursday....

October 12, 2023, 3:17 pm

Sotera health: a great business at a discount

Sotera Health stock has declined 22% in the past six months due to concerns over guidance, rising interest expense, and fears about slower medical dev...

October 12, 2023, 12:32 pm

Superlatus announces distribution partnership with north america’s leading wholesale distributor and expanded points of retail sales

TAMPA, FL, Oct. 12, 2023 (GLOBE NEWSWIRE) — Superlatus, Inc. (“Superlatus”), a food technology and distribution company and wholly owned subsidi...

October 12, 2023, 12:05 pm

Is boston scientific (bsx) stock outpacing its medical peers this year?

Here is how Boston Scientific (BSX) and Chugai pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) have pe...

October 12, 2023, 11:17 am

Olema oncology kat6 inhibitor compounds demonstrate potent anti-tumor activity

Preclinical data to be presented at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics SAN FRANCISCO, Oct. ...

October 12, 2023, 11:01 am


Search within

Pages Search Results: